Compare DKS Co., Ltd. with Similar Stocks
Dashboard
1
With a growth in Operating Profit of 4.34%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 10 consecutive quarters
- ROCE(HY) Highest at 13.59%
- DEBT-EQUITY RATIO (HY) Lowest at 9.83 %
- INTEREST COVERAGE RATIO(Q) Highest at 5,933.33
2
With ROCE of 15.27%, it has a attractive valuation with a 1.79 Enterprise value to Capital Employed
3
Consistent Returns over the last 3 years
Stock DNA
Specialty Chemicals
JPY 125,327 Million (Small Cap)
15.00
NA
0.00%
0.16
12.87%
2.58
Revenue and Profits:
Net Sales:
22,677 Million
(Quarterly Results - Mar 2026)
Net Profit:
2,334 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
62.96%
0%
62.96%
6 Months
57.14%
0%
57.14%
1 Year
246.46%
0%
246.46%
2 Years
264.64%
0%
264.64%
3 Years
649.15%
0%
649.15%
4 Years
572.1%
0%
572.1%
5 Years
303.05%
0%
303.05%
DKS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.18%
EBIT Growth (5y)
14.90%
EBIT to Interest (avg)
14.40
Debt to EBITDA (avg)
2.72
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.00
Tax Ratio
26.43%
Dividend Payout Ratio
37.04%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
6.73%
ROE (avg)
7.07%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.91
EV to EBIT
11.70
EV to EBITDA
8.56
EV to Capital Employed
1.79
EV to Sales
1.27
PEG Ratio
0.25
Dividend Yield
NA
ROCE (Latest)
15.27%
ROE (Latest)
12.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
22,677.00
22,598.00
0.35%
Operating Profit (PBDIT) excl Other Income
3,916.00
3,973.00
-1.43%
Interest
66.00
71.00
-7.04%
Exceptional Items
-286.00
0.00
Consolidate Net Profit
2,334.00
2,412.00
-3.23%
Operating Profit Margin (Excl OI)
134.40%
141.20%
-0.68%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.35% vs 21.72% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -3.23% vs 80.95% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
82,886.00
73,255.00
13.15%
Operating Profit (PBDIT) excl Other Income
13,329.00
8,575.00
55.44%
Interest
280.00
260.00
7.69%
Exceptional Items
-286.00
-365.00
21.64%
Consolidate Net Profit
7,299.00
3,820.00
91.07%
Operating Profit Margin (Excl OI)
122.00%
73.10%
4.89%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 13.15% vs 16.06% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 91.07% vs 132.64% in Mar 2025
About DKS Co., Ltd. 
DKS Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






